4
Changes in Ownership
Vor Biopharma Inc. Filed Acc 0002079210-25-000003
Options or other derivatives
- Chief Development Officer acquired 218,652 shares (grant or award)
- Chief Development Officer returned 218,652 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Zuraw Qing Che Chief Development Officer | 2025-12-05 | Returned to the company · Employee Stock Option (right to buy) | −218,652 | 0 | D | ||
| Zuraw Qing Che Chief Development Officer | 2025-12-05 | Grant or award · Employee Stock Option (right to buy) | +218,652 | 218,652 | D | ||
Loading xslF345X05/form4-12092025_081203.xml…